A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...

Thermo Fisher Scientific Inc. acts as a mission-critical supplier and service partner for the global life science industry.

They look like ordinary horses, with their honey brown coats and white patches. But these 10-month-old foals in Argentina are the world's first gene-edited horses, according to scientists. Experts say ...

CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

The Monash Boston Hub is building a bigger bridge between Boston and Melbourne - two of the world’s leading centers of ...

Over the past few decades, biomedical researchers and neuroscientists have devised increasingly advanced techniques to study ...

One key finding is that deleting CDKN1B, a cell cycle regulator, increased CAR T cell proliferation and improved therapy persistence.

The share of U.S. startup investment going to biotech companies has hit the lowest level in more than 20 years, as an ever-growing proportion of funding goes to AI upstarts in other sectors. We take a ...